The Effects of Transforming Growth Factor-β2 on Dopaminergic Graft Survival

Cell Transplantation

Volumn 13, Issue 3, 2004, Pages 245-252

  Macauley, Shannon L ^a   Horsch, Alexander D ^b   Oterdoom, Marinus ^c   Zheng, Ming H ^a   Stewart, Gregory R ^a  

^a GENZYME CORPORATION   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Neuroprotection; Neurotrophic; Parkinson's disease; TGF ; Transplantation

Indexed keywords

NEUROTROPHIC FACTOR; TRANSFORMING GROWTH FACTOR BETA2; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL INFILTRATION; CELL POPULATION; CELL SURVIVAL; CELL SUSPENSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; GRAFT SURVIVAL; MALE; MESENCEPHALON; NERVE CELL; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 2442517443     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000004783984043     Document Type: Article

References (55)

1. Abercrombie, M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:239-247; 1946.
2. Apostolides, C.; Sanford, D.; Hong, M.; Mendez, I. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience 83(2):363-372; 1998.
3. Barker, R. A.; Dunnet, S. B.; Faissner, A.; Fawcett, J. W. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol. 141:79-93; 1996.
4. Björklund, A.; Stenevia, U.; Dunnett, S. B.; Gage, F. H. Cross-species neural grafting in a rat model of Parkinson's disease. Nature 298:652-654; 1982.
5. Björklund, A. Dopaminergic transplants in experimental parkinsonism: Cellular mechanisms of graft-induced functional recovery. Curr. Opin. Neurobiol. 2:683-689; 1992.
6. Brundin, P.; Isacson, O.; Björklund, A. Monitoring cell viability in suspensions of embryonic CNS tissue and its use as a criterion of intracerebral graft survival. Brain Res. 331:251-259; 1985.
7. Brundin, P.; Björklund, A. Survival, growth, and function of dopaminergic neurons grafted to the brain. Prog. Brain Res. 71:293-308; 1987.
8. Brundin, P.; Strecker, R. E.; Widner, H.; Clarke, D. J.; Nilsson, O. G.; Astedt, B.; Lindvall, O.; Björklund, A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res. 70:192-208; 1988.
9. Brundin, P.; Karlsson, J.; Emgård, M.; Schierle, G. S.; Hansson, O.; Petersén, Å.; Castilho, R. F. Improving the survival of grafted dopaminergic neurons: A review over current approaches. Cell Transplant. 9:179-195; 2000.
10. Constantini, L. C.; Lin, L.; Isacson, O. Medial fetal ventral mesencephalon: A preferred source for dopamine neuron grafts. Neuroreport 8:2253-2257; 1997.
11. Dunnett, S. B.; Hernandez, T. D.; Summerfield, A.; Jones, G. H.; Arbuthnott, G. Graft-derived recovery from 6-OHDA lesions: Specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 71:411-424; 1988.
12. Emgård, M.; Blomgren, K.; Brundin, P. Characterization of cell damage and death in embryonic mesencephalic tissue: A study on ultrastructure, vital stains and protease activity. Neuroscience 115(4):1177-1187; 2002.
13. Espejo, M.; Cutillas, B.; Arenas, E.; Ambrosio, S. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor. Cell Transplant. 9:45-53; 2000.
14. Flanders, K. C.; Ren, R. F.; Lippa, C. F. Transforming growth factor-β's in neurodegenerative disease. Prog. Neurbiol. 54:71-85; 1998.
15. Freed, C. R.; Greene, P. E.; Breeze, R. E.; Tsai, W. Y.; DuMouchel, W.; Kao, R.; Dillon, S.; Winfield, H.; Culver, S.; Trojanowski, J. Q.; Eidelberg, D.; Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344(10):710-719; 2001.
16. Freed, W. J.; Perlow, M. J.; Karoum, F.; Seiger, A.; Olson, L.; Hoffer, B. J.; Wyatt, R. J. Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: Long-term behavioral, biochemical, and histochemical studies. Ann. Neurol. 8:510-519; 1980.
17. Frodl, E. M.; Duan, W. M.; Sauer, H.; Kupsch, A.; Brundin, P. Human embryonic dopamine neurons xenografted to the rats: Effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res. 647:286-298; 1994.
18. Granholm, A.-C.; Mott, J. L.; Bowenkamp, S.; Eken, S.; Henry, S.; Hoffer, B. J.; Pachak, P. A.; Palmer, M. R.; van Home, C.; Gerhardt, G. A. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp. Brain Res. 116:29-38; 1997.
19. Helt, C. E.; Hoernig, G. R.; Albeck, D. S.; Gerhardt, G. A.; Ickes, B.; Reyland, M. E.; Quissell, D. O.; Stromberg, I.; Granholm, A. C. Neuroprotection of grafted neurons with a GDNF/caspase inhibitor cocktail. Exp. Neurol. 170:258-269; 2001.
20. Herman, J. P.; Abrous, N. D. Dopaminergic neural grafts after fifteen years: Results and perspectives. Prog. Neurbiol. 44(1):1-35; 1994.
21. Hurelbrink, C. B.; Armstrong, R. J. E.; Luheshi, L. M.; Dunnet, S. B.; Rosser, A. E.; Barker, R. A. Death of dopaminergic neurons in vitro and in nigral grafts: Reevaluating the role of caspase activation. Exp. Neurol. 171:46-58; 2001.
22. Karlsson, J.; Emgård, M.; Gido, G.; Wieloch, T.; Brundin, P. Increased survival of embryonic nigral neurons when grafted to hypothermic rats. Neuroreport 11:1665-1668; 2000.
23. Krieglstein, K.; Unsicker, K. Transforming growth factor-β promotes survival of midbrain dopaminergic neurons and protects them against n-methyl-4-phenylpyridinium ion toxicity. Neuroscience 63(4):1189-1196; 1994.
24. Krieglstein, K.; Rufer, M.; Suter-Crazzolara, C.; Unsicker, K. Neural functions of the transforming growth factor β. Int. J. Dev. Neurosci. 13(3-4):301-315; 1995.
25. Krieglstein, K.; Suter-Crazzolara, C.; Fischer, W. H.; Unsicker, K. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 14(4):736-742; 1995.
26. Krieglstein, K.; Suter-Crazzolara, C.; Unsicker, K. Development of mesencephalic dopaminergic neurons and the transforming growth factor β superfamily. J. Neural Transm. 46:209-216; 1995.
27. Krieglstein, K.; Maysinger, D.; Unsicker, K. The survival response of mesencephalic dopaminergic neurons to the neurotrophins BDNF and NT-4 requires priming with serum: Comparison with members of the TGF-β superfamily and characterization of the serum-free culture system. J. Neural Transm. 47: 247-258; 1996.
28. Krieglstein, K.; Farkas, L.; Unsicker, K. TGF-beta regulates the survival of ciliary ganglionic neurons synergistically with ciliary neurotrophic factor and neurotrophins. J. Neurobiol. 37(4):563-572; 1998.
29. Krieglstein, K.; Henheik, P.; Farkas, L.; Jaszai, J.; Galter, D.; Krohn, K.; Unsicker, K. Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons. J. Neurosci. 18(23):9822-9834; 1998.
30. Krieglstein, K.; Reuss, B.; Maysinger, D.; Unsicker, K. Transforming growth factor-β mediates the neurotrophic effect of fibroblast growth factor-2 on midbrain dopaminergic neurons. Eur. J. Neuorsci. 10:2746-2750; 1998.
31. Krieglstein, K.; Richter, S.; Farkas, L.; Schuster, N.; Dunker, N.; Oppenheim, R. W.; Unsicker, K. Reduction of endogenous transforming growth factor β prevents ontogenetic neuron death. Nat. Neurosci. 3(11): 1085-1090; 2000.
32. Kupsch, A.; Oertel, W. H. Neural transplantation, trophic factors and Parkinson's disease. Life Sci. 55(25/26):2083-2095; 1994.
33. Lawrence, D. A. Transforming growth factor-beta: A general review. Eur. Cytokine Net. 7(3):363-374; 1966.
34. Lindvall, O.; Brundin, P.; Widner, H.; Rehncrona, S.; Gustavii, B.; Frackowiak, R.; Leenders, K. L.; Sawle, G.; Rothwell, J. C.; Marsden, C. D.; Björklund, A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247(4942):574-577; 1990.
35. Luttmann, W.; Franz, P.; Matthys, H.; Virchow, J. C. J. Effects of TGF-beta on eosinophil chemotaxis. Scand. J. Immunol. 47(2):127-130; 1998.
36. Mayer, E.; Fawcett, J. W.; Dunnett, S. B. Basic fibroblast growth factor promotes the survival of embryonic ventral mesecephalic dopaminergic neurons. Neuroscience 56(2):389-398; 1993.
37. Mundt-Petersen, U.; Karlsson, J.; Schierle, G. S.; Brundin, P. Pretreatment with MK-801 or the lazaroid U-83836e does not enhance striatal graft survival. Cell Transplant. 9:73-78; 2000.
38. National Research Council. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press; 1996.
39. Nikkhah, G.; Cunningham, M. G.; Jodicke, A.; Knappe. U.; Björklund, A. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res. 633:133-143; 1993.
40. Petersén, Å.; Hansson, O.; Emgård, M.; Brundin, P. Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor. Cell Transplant. 9:577-584; 2000.
41. Poulsen, K. T.; Armanini, M. P.; Klein, R. D.; Hynes, M. A.; Phillips, H. S.; Rosenthal, A. TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13:1245-1252; 1994.
42. Pratt, B. P.; McPherson, J. M. TGF-β in the central nervous system: Potential roles in ischemic injury and neurodegenerative diseases. Cytokine Growth Factor Rev. 8(4):267-292; 1997.
43. Reibman, J.; Meixler, S.; Lee, T. C.; Gold, L. I.; Cronstein, B. N.; Haines, K. A.; Kolasinski, S. L.; Weissmann, G. Transforming growth factor beta 1. a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proc. Natl Acad. Sci. USA 88(15):6805-6809; 1991.
44. Rosenblad, C.; Martinez-Serrano, A.; Björklund. A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 75(4):979-985; 1996.
45. Rossi, F.; Catteneo, E. Opinion: Neural stem cell therapy for neurological diseases: Dreams and reality. Nat. Rev. Neurosci. 3:401-409; 2002.
46. Sable, V.; Sailaja. K.; Gopinath. G.; Tandon, P. N. Fetal dopaminergic neurons transplanted to normal striatum of neonatal or adult rats and to the denervated striatum of adult rats. J. Neural Transplant. Plast. 6(2):73-81, 1997.
47. Schumacher. J. M.; Ellias. S. A.; Palmer, E. P.; Kott, H. S.; Dinsmore, J.; Dempsey. P. K.; Fischman. A. J.; Thomas, C.; Feldman, R. G., Kassissieh, S. ; Raineri, R.; Manhart, C.; Penney, D.; Fink, J. S.; Isacson, O. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54(5):1042-1050; 2000.
48. Schuster, N.; Krieglstein, K. Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res. 307:1-14; 2002.
49. Sortwell, C. E.; Pitzer, M. R.; Collier, T. J. Time course of apoptotic cell death within mesencephalic cell suspension grafts: Implications for improving grafted dopamine neuron survival. Exp. Neurol. 165(2):268-277; 2000.
50. Sortwell, C. E.; Camargo, M. D.; Pitzer. M. R.; Gyawali, S.; Collier, T. J. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Exp. Neurol. 169: 23-29; 2001.
51. Sullivan, A. M.; Pohl, J.; Blunt, S. B. Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease. Eur. J. Neurosci. 10:3681-3688; 1998.
52. Unsicker, K.; Flanders, K. C.; Cissel, D. S.; Lafyatis, R.; Sporn, M. B. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience 44:613-625; 1991.
53. Unsicker, K. GDNF: A cytokine at the interface of TGF-βs and neurotrophins. Cell Tissue Res. 286:175-178; 1996.
54. Yurek, D. M. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue. Exp. Neurol. 153:195-202; 1998.
55. Zawada, W. M.; Zastrow, D. J.; Clarkson, E. D.; Adams, F. S.; Bell, K. P.; Freed, C. R. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786:96-103; 1998.